Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Ocaña

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|September 3, 2010
Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cellsSamuel Seoane, Juan Carlos Montero, Alberto Ocaña, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2011
Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumorsJuan Carlos Montero, Samuel Seoane, Alberto Ocaña, et al.
Molecular Cancer Therapeutics|April 13, 2012
Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implicationsJuan Carlos Montero, Xi Chen, Alberto Ocaña, et al.
Journal of the National Cancer Institute|September 19, 2012
Benefits and harms of detecting clinically occult breast cancerEitan Amir, Philippe L Bedard, Alberto Ocaña, et al.
Revista De Biologia Tropical|May 23, 2008
[Larval development of some Bregmaceros species (Pisces: Bregmacerotidae) from the southeast Gulf of Mexico]Jorge Blas-Cabrera, Marina Sánchez-Ramírez, Alberto Ocaña-Luna
Trends in Pharmacological Sciences|October 4, 2018
Refining Early Antitumoral Drug DevelopmentAlberto Ocaña, Sara García-Alonso, Eitan Amir, et al.
Cancers|January 11, 2022
Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCsElena Díaz-Rodríguez, Lucía Gandullo-Sánchez, Alberto Ocaña, et al.
Journal of the National Cancer Institute|July 12, 2011
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisEitan Amir, Bostjan Seruga, Saroj Niraula, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 13, 2025
PROTAC delivery systems: Innovative approaches for cancer treatmentMaría Arenas-Moreira, Alberto Ocaña, Iván Bravo, et al.
Cancer Metastasis Reviews|December 17, 2013
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumorsAlberto Ocaña, Orit Freedman, Eitan Amir, et al.
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|September 3, 2010
Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cellsSamuel Seoane, Juan Carlos Montero, Alberto Ocaña, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2011
Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumorsJuan Carlos Montero, Samuel Seoane, Alberto Ocaña, et al.
Molecular Cancer Therapeutics|April 13, 2012
Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implicationsJuan Carlos Montero, Xi Chen, Alberto Ocaña, et al.
Journal of the National Cancer Institute|September 19, 2012
Benefits and harms of detecting clinically occult breast cancerEitan Amir, Philippe L Bedard, Alberto Ocaña, et al.
Revista De Biologia Tropical|May 23, 2008
[Larval development of some Bregmaceros species (Pisces: Bregmacerotidae) from the southeast Gulf of Mexico]Jorge Blas-Cabrera, Marina Sánchez-Ramírez, Alberto Ocaña-Luna
Trends in Pharmacological Sciences|October 4, 2018
Refining Early Antitumoral Drug DevelopmentAlberto Ocaña, Sara García-Alonso, Eitan Amir, et al.
Cancers|January 11, 2022
Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCsElena Díaz-Rodríguez, Lucía Gandullo-Sánchez, Alberto Ocaña, et al.
Journal of the National Cancer Institute|July 12, 2011
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisEitan Amir, Bostjan Seruga, Saroj Niraula, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 13, 2025
PROTAC delivery systems: Innovative approaches for cancer treatmentMaría Arenas-Moreira, Alberto Ocaña, Iván Bravo, et al.
Cancer Metastasis Reviews|December 17, 2013
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumorsAlberto Ocaña, Orit Freedman, Eitan Amir, et al.
Pageof 17